Overview

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Aim of this study is to compare the blood pressure lowering effect of a new drug formulation of eprosartan. Eprosartan belongs to a class of blood pressure lowering agents used worldwide since years with proven efficacy. The new formulation is compared to the currently marketed eprosartan tablet. Equivalent efficacy in blood pressure lowering effects should be demonstrated.
Phase:
Phase 3
Details
Lead Sponsor:
Abbott
Collaborators:
author! et al. BV
Quintiles, Inc.
Synexus
Treatments:
Eprosartan